Oragenics Inc (OGEN) bonds

OGENNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30

$0.20−0.15 (-42.59%)

Close on Nov 13, 2026Market cap $906.90KP/E –Yield –

Debt

Borrowings on the balance sheet, Sep 30, 2026

Oragenics reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in Oragenics's 10-K for the period ended Mar 13, 2025

Issue	Coupon	Carrying value
Promissory Note	20.00%	$3.00M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-K.

See a number that looks wrong?